Perseus Proteomics Inc (4882)

Currency in JPY
158.00
+8.00(+5.33%)
Closed·
4882 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
149.00158.00
52 wk Range
142.00425.00
Key Statistics
Bid/Ask
156.00 / 158.00
Prev. Close
150
Open
149
Day's Range
149-158
52 wk Range
142-425
Volume
291.4K
Average Volume (3m)
534.56K
1-Year Change
-61.7433%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4882 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 14, 2026
EPS / Forecast
-11.03 / --
Revenue / Forecast
32M / --
EPS Revisions
Last 90 days

4882 Income Statement

Compare 4882 to Peers and Sector

Metrics to compare
4882
Peers
Sector
Relationship
P/E Ratio
−3.6x−7.8x−0.4x
PEG Ratio
−0.15−0.130.00
Price/Book
2.1x3.6x2.6x
Price / LTM Sales
18.9x22.4x3.0x
Upside (Analyst Target)
-100.8%51.9%
Fair Value Upside
Unlock13.8%9.1%Unlock

Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. Perseus Proteomics Inc. has a joint research agreement with ASKA Pharmaceutical Co., Ltd. for the development of new antibody drugs and therapeutic drugs for specific disease areas. Perseus Proteomics Inc. was incorporated in 2001 and is headquartered in Tokyo, Japan.

Employees
35
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
48.80K0.29%7.27M
Other Institutional Investors
679.00K3.99%101.17M
Public Companies & Retail Investors
16.27M95.72%2.42B
Total
17M100.00%2.53B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SBI Holdings, Inc.3.56%606,00090,294
Macquarie Group Limited0.43%73,00010,877

FAQ

What Is the Perseus Proteomics (4882) Stock Price Today?

The Perseus Proteomics stock price today is 158.00 JPY.

What Stock Exchange Does Perseus Proteomics Trade On?

Perseus Proteomics is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Perseus Proteomics?

The stock symbol for Perseus Proteomics is "4882."

What Is the Perseus Proteomics Market Cap?

As of today, Perseus Proteomics market cap is 2.55B JPY.

What Is Perseus Proteomics's Earnings Per Share (TTM)?

The Perseus Proteomics EPS (TTM) is -48.17.

When Is the Next Perseus Proteomics Earnings Date?

Perseus Proteomics will release its next earnings report on Aug 19, 2026.

From a Technical Analysis Perspective, Is 4882 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Perseus Proteomics Stock Split?

Perseus Proteomics has split 0 times.

How Many Employees Does Perseus Proteomics Have?

Perseus Proteomics has 35 employees.

What is the current trading status of Perseus Proteomics (4882)?

As of Jul 10, 2026, Perseus Proteomics (4882) is trading at a price of 158.00 JPY, with a previous close of 150.00 JPY. The stock has fluctuated within a day range of 149.00 JPY to 158.00 JPY, while its 52-week range spans from 142.00 JPY to 425.00 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.